MEK162
Description: An orally administered small-molecule inhibitor of MEK1 and MEK2 investigated as a treatment for cancers with MAPK pathway alterations.
Primary topic: Melanoma and MAPK Pathways (37%)
Wikidata ID: wiki/Q19903515
OpenAlex ID: keywords/mek162
